Critical involvement of the motor cortex in the pathophysiology and treatment of Parkinson's disease

Neuroscience and Biobehavioral Reviews

Volumn 37, Issue 10, 2013, Pages 2737-2750

  Lindenbach, David ^a   Bishop, Christopher ^a  

^a BINGHAMTON UNIVERSITY   (United States)

Author keywords

Deep brain stimulation; Dopamine; Functional imaging; Motor cortex; Parkinson's disease; Plasticity; Premotor cortex; Supplementary motor area; Transcranial magnetic stimulation

Indexed keywords

AMANTADINE; APOMORPHINE; DOPA; DOPAMINE;

BRAIN BLOOD FLOW; BRAIN DEPTH STIMULATION; BRAIN METABOLISM; BRAIN STEM; CLINICAL EFFECTIVENESS; GRAY MATTER; HUMAN; LEWY BODY; MOTOR CORTEX; NERVE CELL; NERVE CELL EXCITABILITY; NERVE CELL PLASTICITY; NEUROANATOMY; NONHUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; TRANSCRANIAL MAGNETIC STIMULATION; WHITE MATTER;

DEEP BRAIN STIMULATION; DOPAMINE; FUNCTIONAL IMAGING; MOTOR CORTEX; PARKINSON'S DISEASE; PLASTICITY; PREMOTOR CORTEX; SUPPLEMENTARY MOTOR AREA; TRANSCRANIAL MAGNETIC STIMULATION;

DEEP BRAIN STIMULATION; DOPAMINE; HUMANS; MOTOR CORTEX; PARKINSON DISEASE;

EID: 84889689428     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2013.09.008     Document Type: Review

References (171)

1. Abe M., Hanakawa T. Functional coupling underlying motor and cognitive functions of the dorsal premotor cortex. Behavioral Brain Research 2009, 198:13-23.
2. Ahlskog J.E., Muenter M.D. Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature. Movement Disorders 2001, 16:448-458.
3. Ahmed I., Bose S.K., Pavese N., Ramlackhansingh A., Turkheimer F., Hotton G., Hammers A., Brooks D.J. Glutamate NMDA receptor dysregulation in Parkinson's disease with dyskinesias. Brain 2011, 134:979-986.
4. Aroniadou V.A., Keller A. The patterns and synaptic properties of horizontal intracortical connections in the rat motor cortex. Journal of Neurophysiology 1993, 70:1553-1569.
5. Asanuma K., Tang C., Ma Y., Dhawan V., Mattis P., Edwards C., Kaplitt M.G., Feigin A., Eidelberg D. Network modulation in the treatment of Parkinson's disease. Brain 2006, 129:2667-2678.
6. Awenowicz P.W., Porter L.L. Local application of dopamine inhibits pyramidal tract neuron activity in the rodent motor cortex. Journal of Neurophysiology 2002, 88:3439-3451.
7. Bagnato S., Agostino R., Modugno N., Quartarone A., Berardelli A. Plasticity of the motor cortex in Parkinson's disease patients on and off therapy. Movement Disorders 2006, 21:639-645.
8. Bamford N.S., Zhang H., Schmitz Y., Wu N.P., Cepeda C., Levine M.S., Schmauss C., Zakharenko S.S., Zablow L., Sulzer D. Heterosynaptic dopamine neurotransmission selects sets of corticostriatal terminals. Neuron 2004, 42:653-663.
9. Baumer T., Hidding U., Hamel W., Buhmann C., Moll C.K.E., Gerloff C., Orth M., Siebner H.R., Munchau A. Effects of DBS, premotor rTMS, and levodopa on motor function and silent period in advanced Parkinson's disease. Movement Disorders 2009, 24:672-676.
10. Ben-Shachar D., Belmaker R.H., Grisaru N., Klein E. Transcranial magnetic stimulation induces alterations in brain monoamines. Journal of Neural Transmission 1997, 104:191-197.
11. Berding G., Odin P., Brooks D.J., Nikkhah G., Matthies C., Peschel T., Shing M., Kolbe H., van Den Hoff J., Fricke H., Dengler R., Samii M., Knapp W.H. Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [(18)F]FDG-PET. Movement Disorders 2001, 16:1014-1022.
12. Berger B., Gaspar P., Verney C. Dopaminergic innervation of the cerebral cortex: unexpected differences between rodents and primates. Trends in Neurosciences 1991, 14:21-27.
13. Bergman H., Feingold A., Nini A., Raz A., Slovin H., Abeles M., Vaadia E. Physiological aspects of information processing in the basal ganglia of normal and parkinsonian primates. Trends in Neurosciences 1998, 21:32-38.
14. Bernardi G., Cherubini E., Marciani M.G., Mercuri N., Stanzione P. Responses of intracellularly recorded cortical neurons to the iontophoretic application of dopamine. Brain Research 1982, 245:267-274.
15. Braak H., Del Tredici K. Cortico-basal ganglia-cortical circuitry in Parkinson's disease reconsidered. Experimental Neurology 2008, 212:226-229.
16. Braak H., Del Tredici K., Rub U., de Vos R.A., Jansen Steur E.N., Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiology of Aging 2003, 24:197-211.
17. Brazhnik E., Cruz A.V., Avila I., Wahba M.I., Novikov N., Ilieva N.M., McCoy A.J., Gerber C., Walters J.R. State-dependent spike and local field synchronization between motor cortex and substantia nigra in hemiparkinsonian rats. Journal of Neuroscience 2012, 32:7869-7880.
18. Bronstein J.M., Tagliati M., Alterman R.L., Lozano A.M., Volkmann J., Stefani A., Horak F.B., Okun M.S., Foote K.D., Krack P., Pahwa R., Henderson J.M., Hariz M.I., Bakay R.A., Rezai A., Marks W.J., Moro E., Vitek J.L., Weaver F.M., Gross R.E., DeLong M.R. Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. Archives of Neurology 2011, 68:165.
19. Brown A.R., Antle M.C., Hu B., Teskey G.C. High frequency stimulation of the subthalamic nucleus acutely rescues motor deficits and neocortical movement representations following 6-hydroxydopamine administration in rats. Experimental Neurology 2011, 231:82-90.
20. Brown A.R., Hu B., Antle M.C., Teskey G.C. Neocortical movement representations are reduced and reorganized following bilateral intrastriatal 6-hydroxydopamine infusion and dopamine type-2 receptor antagonism. Experimental Neurology 2009, 220:162-170.
21. Brown P. Abnormal oscillatory synchronisation in the motor system leads to impaired movement. Current Opinion in Neurobiology 2007, 17:656-664.
22. Brown P., Oliviero A., Mazzone P., Insola A., Tonali P., Di Lazzaro V. Dopamine dependency of oscillations between subthalamic nucleus and pallidum in Parkinson's disease. Journal of Neuroscience 2001, 21:1033-1038.
23. Calabresi P., Pisani A., Mercuri N.B., Bernardi G. The corticostriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia. Trends in Neurosciences 1996, 19:19-24.
24. Canedo A. Primary motor cortex influences on the descending and ascending systems. Progress in Neurobiology 1997, 51:287-335.
25. Cantello R., Gianelli M., Bettucci D., Civardi C., De Angelis M.S., Mutani R. Parkinson's disease rigidity: magnetic motor evoked potentials in a small hand muscle. Neurology 1991, 41:1449-1456.
26. Catalan M.J., Ishii K., Honda M., Samii A., Hallett M. A PET study of sequential finger movements of varying length in patients with Parkinson's disease. Brain 1999, 122:483-495.
27. Caviness J.N., Lue L.-F., Beach T.G., Hentz J.G., Adler C.H., Sue L., Sadeghi R., Driver-Dunckley E., Evidente V.G., Sabbagh M.N., Shill H.A., Walker D.G. Parkinson's disease, cortical dysfunction, and alpha-synuclein. Movement Disorders 2011, 26:1436-1442.
28. Ceballos-Baumann A.O. Functional imaging in Parkinson's disease: activation studies with PET, fMRI and SPECT. Journal of Neurology 2003, 250:I15-I23.
29. Ceballos-Baumann A.O., Boecker H., Bartenstein P., von Falkenhayn I., Riescher H., Conrad B., Moringlane J.R., Alesch F. A positron emission tomographic study of subthalamic nucleus stimulation in Parkinson disease: enhanced movement-related activity of motor-association cortex and decreased motor cortex resting activity. Archives of Neurology 1999, 56:997-1003.
30. Cenci M.A. Dopamine dysregulation of movement control in l-DOPA-induced dyskinesia. Trends in Neurosciences 2007, 30:236-243.
31. Cenci M.A., Ohlin K.E., Odin P. Current options and future possibilities for the treatment of dyskinesia and motor fluctuations in Parkinson's disease. CNS and Neurological Disorders Drug Targets 2011, 10:670-684.
32. Cerasa A., Messina D., Pugliese P., Morelli M., Lanza P., Salsone M., Novellino F., Nicoletti G., Arabia G., Quattrone A. Increased prefrontal volume in PD with levodopa-induced dyskinesias: a voxel-based morphometry study. Movement Disorders 2011, 26:807-812.
33. Chen C., Litvak V., Gilbertson T., Kuhn A., Lu C., Lee S., Tsai C., Tisch S., Limousin P., Hariz M. Excessive synchronization of basal ganglia neurons at 20Hz slows movement in Parkinson's disease. Experimental Neurology 2007, 205:214-221.
34. Chen R. Interactions between inhibitory and excitatory circuits in the human motor cortex. Experimental Brain Research 2004, 154:1-10.
35. Chen R., Garg R.R., Lozano A.M., Lang A.E. Effects of internal globus pallidus stimulation on motor cortex excitability. Neurology 2001, 56:716-723.
36. Chen R., Kumar S., Garg R.R., Lang A.E. Impairment of motor cortex activation and deactivation in Parkinson's disease. Clinical Neurophysiology 2001, 112:600-607.
37. Costa R.M., Lin S.C., Sotnikova T.D., Cyr M., Gainetdinov R.R., Caron M.G., Nicolelis M.A. Rapid alterations in corticostriatal ensemble coordination during acute dopamine-dependent motor dysfunction. Neuron 2006, 52:359-369.
38. Coull J.T., Hwang H.J., Leyton M., Dagher A. Dopamine precursor depletion impairs timing in healthy volunteers by attenuating activity in putamen and supplementary motor area. Journal of Neuroscience 2012, 32:16704-16715.
39. Crowell A.L., Ryapolova-Webb E.S., Ostrem J.L., Galifianakis N.B., Shimamoto S., Lim D.A., Starr P.A. Oscillations in sensorimotor cortex in movement disorders: an electrocorticography study. Brain 2012, 135:615-630.
40. Cunic D., Roshan L., Khan F.I., Lozano A.M., Lang A.E., Chen R. Effects of subthalamic nucleus stimulation on motor cortex excitability in Parkinson's disease. Neurology 2002, 58:1665-1672.
41. Dauer W., Przedborski S. Parkinson's disease: mechanisms and models. Neuron 2003, 39:889-909.
42. Davis K.D., Taub E., Houle S., Lang A.E., Dostrovsky J.O., Tasker R.R., Lozano A.M. Globus pallidus stimulation activates the cortical motor system during alleviation of parkinsonian symptoms. Nature Medicine 1997, 3:671-674.
43. Debeir T., Ginestet L., Francois C., Laurens S., Martel J.C., Chopin P., Marien M., Colpaert F., Raisman-Vozari R. Effect of intrastriatal 6-OHDA lesion on dopaminergic innervation of the rat cortex and globus pallidus. Experimental Neurology 2005, 193:444-454.
44. Dejean C., Hyland B., Arbuthnott G. Cortical effects of subthalamic stimulation correlate with behavioral recovery from dopamine antagonist induced akinesia. Cerebral Cortex 2009, 19:1055-1063.
45. Donoghue J.P., Wise S.P. The motor cortex of the rat: cytoarchitecture and microstimulation mapping. Journal of Comparative Neurology 1982, 212:76-88.
46. Doudet D.J., Gross C., Arluison M., Bioulac B. Modifications of precentral cortex discharge and EMG activity in monkeys with MPTP-induced lesions of DA nigral neurons. Experimental Brain Research 1990, 80:177-188.
47. Doyon J. Motor sequence learning and movement disorders. Current Opinion in Neurology 2008, 21:478-483.
48. Drouot X., Oshino S., Jarraya B., Besret L., Kishima H., Remy P., Dauguet J., Lefaucheur J.P., Dolle F., Conde F., Bottlaender M., Peschanski M., Keravel Y., Hantraye P., Palfi S. Functional recovery in a primate model of Parkinson's disease following motor cortex stimulation. Neuron 2004, 44:769-778.
49. Ebrahimi A., Pochet R., Roger M. Topographical organization of the projections from physiologically identified areas of the motor cortex to the striatum in the rat. Neuroscience Research 1992, 14:39-60.
50. Eggers C., Fink G.R., Nowak D.A. Theta burst stimulation over the primary motor cortex does not induce cortical plasticity in Parkinson's disease. Journal of Neurology 2010, 257:1669-1674.
51. Elahi B., Elahi B., Chen R. Effect of transcranial magnetic stimulation on Parkinson motor function-systematic review of controlled clinical trials. Movement Disorders 2009, 24:357-363.
52. Elsworth J.D., Deutch A.Y., Redmond D.E., Sladek J.R., Roth R.H. MPTP reduces dopamine and norepinephrine concentrations in the supplementary motor area and cingulate cortex of the primate. Neuroscience Letters 1990, 114:316-322.
53. Engel A.K., Fries P. Beta-band oscillations-signalling the status quo?. Current Opinion in Neurobiology 2010, 20:156-165.
54. Escola L., Michelet T., Douillard G., Guehl D., Bioulac B., Burbaud P. Disruption of the proprioceptive mapping in the medial wall of parkinsonian monkeys. Annals of Neurology 2002, 52:581-587.
55. Escola L., Michelet T., Macia F., Guehl D., Bioulac B., Burbaud P. Disruption of information processing in the supplementary motor area of the MPTP-treated monkey: a clue to the pathophysiology of akinesia?. Brain 2003, 126:95-114.
56. Fasano A., Piano C., De Simone C., Cioni B., Di Giuda D., Zinno M., Daniele A., Meglio M., Giordano A., Bentivoglio A.R. High frequency extradural motor cortex stimulation transiently improves axial symptoms in a patient with Parkinson's disease. Movement Disorders 2008, 23:1916-1919.
57. Filipovic S.R., Rothwell J.C., van de Warrenburg B.P., Bhatia K. Repetitive transcranial magnetic stimulation for levodopa-induced dyskinesias in Parkinson's disease. Movement Disorders 2009, 24:246-253.
58. Filipovic S.R., Rothwell J.C., Bhatia K. Low-frequency repetitive transcranial magnetic stimulation and off-phase motor symptoms in Parkinson's disease. Journal of the Neurological Sciences 2010, 291:1-4.
59. Filippi M.M., Oliveri M., Pasqualetti P., Cicinelli P., Traversa R., Vernieri F., Palmieri M.G., Rossini P.M. Effects of motor imagery on motor cortical output topography in Parkinson's disease. Neurology 2001, 57:55-61.
60. Fitzgerald P.B., Fountain S., Daskalakis Z.J. A comprehensive review of the effects of rTMS on motor cortical excitability and inhibition. Clinical Neurophysiology 2006, 117:2584-2596.
61. Floel A., Breitenstein C., Hummel F., Celnik P., Gingert C., Sawaki L., Knecht S., Cohen L.G. Dopaminergic influences on formation of a motor memory. Annals of Neurology 2005, 58:121-130.
62. Fogelson N., Williams D., Tijssen M., van Bruggen G., Speelman H., Brown P. Different functional loops between cerebral cortex and the subthalmic area in Parkinson's disease. Cerebral Cortex 2006, 16:64-75.
63. Follett K.A., Weaver F.M., Stern M., Hur K., Harris C.L., Luo P., Marks W.J., Rothlind J., Sagher O., Moy C., Pahwa R., Burchiel K., Hogarth P., Lai E.C., Duda J.E., Holloway K., Samii A., Horn S., Bronstein J.M., Stoner G., Starr P.A., Simpson R., Baltuch G., De Salles A., Huang G.D., Reda D.J. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. New England Journal of Medicine 2010, 362:2077-2091.
64. Fraix V., Pollak P., Vercueil L., Benabid A.-L., Mauguiere F. Effects of subthalamic nucleus stimulation on motor cortex excitability in Parkinson's disease. Clinical Neurophysiology 2008, 119:2513-2518.
65. Francardo V., Recchia A., Popovic N., Andersson D., Nissbrandt H., Cenci M.A. Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to l-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease. Neurobiology of Disease 2011, 42:327-340.
66. Fregni F., Simon D.K., Wu A., Pascual-Leone A. Non-invasive brain stimulation for Parkinson's disease: a systematic review and meta-analysis of the literature. Journal of Neurology, Neurosurgery & Psychiatry 2005, 76:1614-1623.
67. Garcia L., D'Alessandro G., Bioulac B., Hammond C. High-frequency stimulation in Parkinson's disease: more or less?. Trends in Neurosciences 2005, 28:209-216.
68. Gaspar P., Duyckaerts C., Alvarez C., Javoy-Agid F., Berger B. Alterations of dopaminergic and noradrenergic innervations in motor cortex in Parkinson's disease. Annals of Neurology 1991, 30:365-374.
69. Gaspar P., Stepniewska I., Kaas J.H. Topography and collateralization of the dopaminergic projections to motor and lateral prefrontal cortex in owl monkeys. Journal of Comparative Neurology 1992, 325:1-21.
70. Geyer S., Matelli M., Luppino G., Zilles K. Functional neuroanatomy of the primate isocortical motor system. Anatomy and Embryology 2000, 202:443-474.
71. Ghosh S., Fyffe R.E., Porter R. Morphology of neurons in area 4 gamma of the cat's cortex studied with intracellular injection of HRP. Journal of Comparative Neurology 1988, 277:290-312.
72. Goldberg G. Supplementary motor area structure and function - review and hypotheses. Behavioral and Brain Sciences 1985, 8:567-588.
73. Goldberg J.A., Rokni U., Boraud T., Vaadia E., Bergman H. Spike synchronization in the cortex-basal ganglia networks of parkinsonian primates reflects global dynamics of the local field potentials. Journal of Neuroscience 2004, 24:6003-6010.
74. Goldberg J.A., Boraud T., Maraton S., Haber S.N., Vaadia E., Bergman H. Enhanced synchrony among primary motor cortex neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of Parkinson's disease. Journal of Neuroscience 2002, 22:4639-4653.
75. Goldman-Rakic P.S., Leranth C., Williams S.M., Mons N., Geffard M. Dopamine synaptic complex with pyramidal neurons in primate cerebral cortex. Proceedings of the National Academy of Science 1989, 86:9015-9019.
76. Gradinaru V., Mogri M., Thompson K.R., Henderson J.M., Deisseroth K. Optical deconstruction of parkinsonian neural circuitry. Science 2009, 324:354-359.
77. Gutierrez J.C., Seijo F.J., Vega M.A.Á., González F.F., Aragoneses B.L., Blázquez M. Therapeutic extradural cortical stimulation for Parkinson's disease: report of six cases and review of the literature. Clinical Neurology and Neurosurgery 2009, 111:703-707.
78. Halje P., Tamte M., Richter U., Mohammed M., Cenci M.A., Petersson P. Levodopa-induced dyskinesia is strongly associated with resonant cortical oscillations. Journal of Neuroscience 2012, 32:16541-16551.
79. Hammond C., Bergman H., Brown P. Pathological synchronization in Parkinson's disease: networks, models and treatments. Trends in Neurosciences 2007, 30:357-364.
80. Haslinger B., Erhard P., Kampfe N., Boecker H., Rummeny E., Schwaiger M., Conrad B., Ceballos-Baumann A.O. Event-related functional magnetic resonance imaging in Parkinson's disease before and after levodopa. Brain 2001, 124:558-570.
81. Haslinger B., Kalteis K., Boecker H., Alesch F., Ceballos-Baumann A.O. Frequency-correlated decreases of motor cortex activity associated with subthalamic nucleus stimulation in Parkinson's disease. Neuroimage 2005, 28:598-606.
82. Hershey T., Black K.J., Stambuk M.K., Carl J.L., McGee-Minnich L.A., Perlmutter J.S. Altered thalamic response to levodopa in Parkinson's patients with dopa-induced dyskinesias. Proceedings of the National Academy of Science 1998, 95:12016-12021.
83. Hershey T., Revilla F.J., Wernle A.R., McGee-Minnich L., Antenor J.V., Videen T.O., Dowling J.L., Mink J.W., Perlmutter J.S. Cortical and subcortical blood flow effects of subthalamic nucleus stimulation in PD. Neurology 2003, 61:816-821.
84. Hilker R., Voges J., Weisenbach S., Kalbe E., Burghaus L., Ghaemi M., Lehrke R., Koulousakis A., Herholz K., Sturm V., Heiss W.-D. Subthalamic nucleus stimulation restores glucose metabolism in associative and limbic cortices and in cerebellum: evidence from a FDG-PET study in advanced Parkinson's disease. Journal of Cerebral Blood Flow and Metabolism 2004, 24:7-16.
85. Hokfelt T., Johansson O., Fuxe K., Goldstein M., Park D. Immunohistochemical studies on the localization and distribution of monoamine neuron systems in the rat brain II. Tyrosine hydroxylase in the telencephalon. Medical Biology 1977, 55:21-40.
86. Huang Y.-Z., Edwards M.J., Rounis E., Bhatia K.P., Rothwell J.C. Theta burst stimulation of the human motor cortex. Neuron 2005, 45:201-206.
87. Huang Y.-Z., Rothwell J.C., Lu C.S., Chuang W.L., Chen R.S. Abnormal bidirectional plasticity-like effects in Parkinson's disease. Brain 2011, 134:2312-2320.
88. Hutchison W.D., Dostrovsky J.O., Walters J.R., Courtemanche R., Boraud T., Goldberg J., Brown P. Neuronal oscillations in the basal ganglia and movement disorders: evidence from whole animal and human recordings. Journal of Neuroscience 2004, 24:9240-9243.
89. Jankovic J. Parkinson's disease: clinical features and diagnosis. Journal of Neurology, Neurosurgery & Psychiatry 2008, 79:368-376.
90. Jenkins I.H., Fernandez W., Playford E.D., Lees A.J., Frackowiak R.S., Passingham R.E., Brooks D.J. Impaired activation of the supplementary motor area in Parkinson's disease is reversed when akinesia is treated with apomorphine. Annals of Neurology 1992, 32:749-757.
91. Jeon B.S., Jackson-Lewis V., Burke R.E. 6-Hydroxydopamine lesion of the rat substantia nigra: time course and morphology of cell death. Neurodegeneration 1995, 4:131-137.
92. Jubault T., Gagnon J.-F., Karama S., Ptito A., Lafontaine A.-L., Evans A.C., Monchi O. Patterns of cortical thickness and surface area in early Parkinson's disease. Neuroimage 2011, 55:462-467.
93. Kanno M., Matsumoto M., Togashi H., Yoshioka M., Mano Y. Effects of acute repetitive transcranial magnetic stimulation on dopamine release in the rat dorsolateral striatum. Journal of the Neurological Sciences 2004, 217:73-81.
94. Karagulle Kendi A.T., Lehericy S., Luciana M., Ugurbil K., Tuite P. Altered diffusion in the frontal lobe in Parkinson disease. AJNR - American Journal of Neuroradiology 2008, 29:501-505.
95. Keller A. Intrinsic synaptic organization of the motor cortex. Cerebral Cortex 1993, 3:430-441.
96. Khedr E.M., Farweez H.M., Islam H. Therapeutic effect of repetitive transcranial magnetic stimulation on motor function in Parkinson's disease patients. European Journal of Neurology 2003, 10:567-572.
97. Kita H., Kita T. Cortical stimulation evokes abnormal responses in the dopamine-depleted rat basal ganglia. Journal of Neuroscience 2011, 31:10311-10322.
98. Koch G., Brusa L., Caltagirone C., Peppe A., Oliveri M., Stanzione P., Centonze D. rTMS of supplementary motor area modulates therapy-induced dyskinesias in Parkinson disease. Neurology 2005, 65:623-625.
99. Kojovic M., Bologna M., Kassavetis P., Murase N., Palomar F.J., Berardelli A., Rothwell J.C., Edwards M.J., Bhatia K.P. Functional reorganization of sensorimotor cortex in early Parkinson disease. Neurology 2012, 78:1441-1448.
100. Kroener S., Chandler L.J., Phillips P.E., Seamans J.K. Dopamine modulates persistent synaptic activity and enhances the signal-to-noise ratio in the prefrontal cortex. PLoS ONE 2009, 4:6507.
101. Lefaucheur J.-P., Drouot X., Von Raison F., Ménard-Lefaucheur I., Cesaro P., Nguyen J.-P. Improvement of motor performance and modulation of cortical excitability by repetitive transcranial magnetic stimulation of the motor cortex in Parkinson's disease. Clinical Neurophysiology 2004, 115:2530-2541.
102. Lefaucheur J.-P. Motor cortex dysfunction revealed by cortical excitability studies in Parkinson's disease: influence of antiparkinsonian treatment and cortical stimulation. Clinical Neurophysiology 2005, 116:244-253.
103. Lefaucheur J.-P. Treatment of Parkinson's disease by cortical stimulation. Expert Review of Neurotherapeutics 2009, 9:1755-1771.
104. Lei W., Jiao Y., Del Mar N., Reiner A. Evidence for differential cortical input to direct pathway versus indirect pathway striatal projection neurons in rats. Journal of Neuroscience 2004, 24:8289-8299.
105. Li Q., Ke Y., Chan D.C., Qian Z.M., Yung K.K., Ko H., Arbuthnott G.W., Yung W.H. Therapeutic deep brain stimulation in parkinsonian rats directly influences motor cortex. Neuron 2012, 76:1030-1041.
106. Lidow M.S., Goldman-Rakic P.S. A common action of clozapine, haloperidol, and remoxipride on D1- and D2-dopaminergic receptors in the primate cerebral cortex. Proceedings of the National Academy of Science 1994, 91:4353-4356.
107. Limousin P., Greene J., Pollak P., Rothwell J., Benabid A.L., Frackowiak R. Changes in cerebral activity pattern due to subthalamic nucleus or internal pallidum stimulation in Parkinson's disease. Annals of Neurology 1997, 42:283-291.
108. Limousin P., Krack P., Pollak P., Benazzouz A., Ardouin C., Hoffmann D., Benabid A.L. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. New England Journal of Medicine 1998, 339:1105-1111.
109. Lindvall O., Bjorklund A. The organization of the ascending catecholamine neuron systems in the rat brain as revealed by the glyoxylic acid fluorescence method. Acta Physiologica Scandinavica Supplementum 1974, 412:1-48.
110. Luppino G., Rizzolatti G. The organization of the frontal motor cortex. Physiology 2000, 15:219-224.
111. Lyoo C.H., Ryu Y.H., Lee M.S. Cerebral cortical areas in which thickness correlates with severity of motor deficits of Parkinson's disease. Journal of Neurology 2011, 258:1871-1876.
112. MacDonald V., Halliday G.M. Selective loss of pyramidal neurons in the pre-supplementary motor cortex in Parkinson's disease. Movement Disorders 2002, 17:1166-1173.
113. Magill P.J., Bolam J.P., Bevan M.D. Dopamine regulates the impact of the cerebral cortex on the subthalamic nucleus-globus pallidus network. Neuroscience 2001, 106:313-330.
114. Mallet N., Pogosyan A., Sharott A., Csicsvari J., Bolam J.P., Brown P., Magill P.J. Disrupted dopamine transmission and the emergence of exaggerated beta oscillations in subthalamic nucleus and cerebral cortex. Journal of Neuroscience 2008, 28:4795-4806.
115. Martin J.H. Neuroanatomy Text and Atlas 2003, McGraw-Hill, New York. third ed.
116. Martinu K., Degroot C., Madjar C., Strafella A.P., Monchi O. Levodopa influences striatal activity but does not affect cortical hyper-activity in Parkinson's disease. European Journal of Neuroscience 2012, 35:572-583.
117. Mesulam M.M., Mufson E.J., Levey A.I., Wainer B.H. Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey. Journal of Comparative Neurology 1983, 214:170-197.
118. Molina-Luna K., Pekanovic A., Rohrich S., Hertler B., Schubring-Giese M., Rioult-Pedotti M.S., Luft A.R. Dopamine in motor cortex is necessary for skill learning and synaptic plasticity. PLoS ONE 2009, 4:e7082.
119. Moore D.J., West A.B., Dawson V.L., Dawson T.M. Molecular pathophysiology of Parkinson's disease. Annual Review of Neuroscience 2005, 28:57-87.
120. Morgante F., Espay A.J., Gunraj C., Lang A.E., Chen R. Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias. Brain 2006, 129:1059-1069.
121. Moro E., Schwalb J.M., Piboolnurak P., Poon Y.Y.W., Hamani C., Hung S.W., Arenovich T., Lang A.E., Chen R., Lozano A.M. Unilateral subdural motor cortex stimulation improves essential tremor but not Parkinson's disease. Brain 2011, 134:2096-2105.
122. Muslimovic D., Post B., Speelman J.D., Schmand B. Motor procedural learning in Parkinson's disease. Brain 2007, 130:2887-2897.
123. Nakamura T., Ghilardi M.F., Mentis M., Dhawan V., Fukuda M., Hacking A., Moeller J.R., Ghez C., Eidelberg D. Functional networks in motor sequence learning: abnormal topographies in Parkinson's disease. Human Brain Mapping 2001, 12:42-60.
124. Neafsey E.J., Bold E.L., Haas G., Hurley-Gius K.M., Quirk G., Sievert C.F., Terreberry R.R. The organization of the rat motor cortex: a microstimulation mapping study. Brain Research 1986, 396:77-96.
125. Obeso J.A., Marin C., Rodriguez-Oroz C., Blesa J., Benitez-Temino B., Mena-Segovia J., Rodriguez M., Olanow C.W. The basal ganglia in Parkinson's disease: current concepts and unexplained observations. Annals of Neurology 2008, 64:S30-S46.
126. Obeso J.A., Rodriguez-Oroz M.C., Rodriguez M., Lanciego J.L., Artieda J., Gonzalo N., Olanow C.W. Pathophysiology of the basal ganglia in Parkinson's disease. Trends in Neurosciences 2000, 23:S8-S19.
127. Ostock C.Y., Dupre K.B., Eskow Jaunarajs K.L., Walters H., George J., Krolewski D., Walker P.D., Bishop C. Role of the primary motor cortex in l-DOPA-induced dyskinesia and its modulation by 5-HT1A receptor stimulation. Neuropharmacology 2011, 61:753-760.
128. Pasquereau B., Turner R.S. Primary motor cortex of the Parkinsonian monkey: differential effects on the spontaneous activity of pyramidal tract-type neurons. Cerebral Cortex 2011, 21:1362-1378.
129. Picconi B., Centonze D., Håkansson K., Bernardi G., Greengard P., Fisone G., Cenci M.A., Calabresi P. Loss of bidirectional striatal synaptic plasticity in l-DOPA-induced dyskinesia. Nature Neuroscience 2003, 6:501-506.
130. Pierantozzi M., Palmieri M.G., Marciani M.G., Bernardi G., Giacomini P., Stanzione P. Effect of apomorphine on cortical inhibition in Parkinson's disease patients: a transcranial magnetic stimulation study. Experimental Brain Research 2001, 141:52-62.
131. Pierantozzi M., Palmieri M.G., Mazzone P., Marciani M.G., Rossini P.M., Stefani A., Giacomini P., Peppe A., Stanzione P. Deep brain stimulation of both subthalamic nucleus and internal globus pallidus restores intracortical inhibition in Parkinson's disease paralleling apomorphine effects: a paired magnetic stimulation study. Clinical Neurophysiology 2002, 113:108-113.
132. Pifl C., Schingnitz G., Hornykiewicz O. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey. Neuroscience 1991, 44:591-605.
133. Playford E.D., Jenkins I.H., Passingham R.E., Nutt J., Frackowiak R.S., Brooks D.J. Impaired mesial frontal and putamen activation in Parkinson's disease: a positron emission tomography study. Annals of Neurology 1992, 32:151-161.
134. Pollok B., Krause V., Martsch W., Wach C., Schnitzler A., Sudmeyer M. Motor-cortical oscillations in early stages of Parkinson's disease. Journal of Physiology 2012, 590:3203-3212.
135. Rascol O., Sabatini U., Chollet F., Celsis P., Montastruc J.L., Marc-Vergnes J.P., Rascol A. Supplementary and primary sensory motor area activity in Parkinson's disease. Regional cerebral blood flow changes during finger movements and effects of apomorphine. Archives of Neurology 1992, 49:144-148.
136. Ridding M.C., Inzelberg R., Rothwell J.C. Changes in excitability of motor cortical circuitry in patients with Parkinson's disease. Annals of Neurology 1995, 37:181-188.
137. Rivara C.B., Sherwood C.C., Bouras C., Hof P.R. Stereologic characterization and spatial distribution patterns of Betz cells in the human primary motor cortex. The Anatomical Record 2003, 270:137-151.
138. Rubinstein T.C., Giladi N., Hausdorff J.M. The power of cueing to circumvent dopamine deficits: a review of physical therapy treatment of gait disturbances in Parkinson's disease. Movement Disorders 2002, 17:1148-1160.
139. Ryan L.J., Clark K.B. The role of the subthalamic nucleus in the response of globus pallidus neurons to stimulation of the prelimbic and agranular frontal cortices in rats. Experimental Brain Research 1991, 86:641-651.
140. Sabatini U., Boulanouar K., Fabre N., Martin F., Carel C., Colonnese C., Bozzao L., Berry I., Montastruc J.L., Chollet F., Rascol O. Cortical motor reorganization in akinetic patients with Parkinson's disease: a functional MRI study. Brain 2000, 123:394-403.
141. Samuel M., Ceballos-Baumann A.O., Blin J., Uema T., Boecker H., Passingham R.E., Brooks D.J. Evidence for lateral premotor and parietal overactivity in Parkinson's disease during sequential and bimanual movements. A PET study. Brain 1997, 120:963-976.
142. Schneidman E., Bialek W., Berry M.J. Synergy, redundancy, and independence in population codes. Journal of Neuroscience 2003, 23:11539-11553.
143. Schnitzler A., Gross J. Normal and pathological oscillatory communication in the brain. Nature Reviews Neuroscience 2005, 6:285-296.
144. Schoffelen J.M., Oostenveld R., Fries P. Neuronal coherence as a mechanism of effective corticospinal interaction. Science 2005, 308:111-113.
145. Sharott A., Magill P.J., Harnack D., Kupsch A., Meissner W., Brown P. Dopamine depletion increases the power and coherence of β-oscillations in the cerebral cortex and subthalamic nucleus of the awake rat. European Journal of Neuroscience 2005, 21:1413-1422.
146. Silberstein P., Pogosyan A., Kuhn A.A., Hotton G., Tisch S., Kupsch A., Dowsey-Limousin P., Hariz M.I., Brown P. Cortico-cortical coupling in Parkinson's disease and its modulation by therapy. Brain 2005, 128:1277-1291.
147. Singer W. Neuronal synchrony: a versatile code for the definition of relations?. Neuron 1999, 24:49-65. 111-125.
148. Smiley J.F., Levey A.I., Ciliax B.J., Goldman-Rakic P.S. D1 dopamine receptor immunoreactivity in human and monkey cerebral cortex: predominant and extrasynaptic localization in dendritic spines. Proceedings of the National Academy of Science 1994, 91:5720-5724.
149. Stefan K., Kunesch E., Cohen L.G., Benecke R., Classen J. Induction of plasticity in the human motor cortex by paired associative stimulation. Brain 2000, 123:572-584.
150. Stowe R.L., Ives N.J., Clarke C., van Hilten J., Ferreira J., Hawker R.J., Shah L., Wheatley K., Gray R. Dopamine agonist therapy in early Parkinson's disease. Cochrane Database of Systematic Reviews 2009, CD006564.
151. Strafella A.P., Ko J.H., Grant J., Fraraccio M., Monchi O. Corticostriatal functional interactions in Parkinson's disease: a rTMS/[11C]raclopride PET study. European Journal of Neuroscience 2005, 22:2946-2952.
152. Strafella A.P., Paus T., Fraraccio M., Dagher A. Striatal dopamine release induced by repetitive transcranial magnetic stimulation of the human motor cortex. Brain 2003, 126:2609-2615.
153. Strafella A.P., Valzania F., Nassetti S.A., Tropeani A., Bisulli A., Santangelo M., Tassinari C.A. Effects of chronic levodopa and pergolide treatment on cortical excitability in patients with Parkinson's disease: a transcranial magnetic stimulation study. Clinical Neurophysiology 2000, 111:1198-1202.
154. Suppa A., Marsili L., Belvisi D., Conte A., Iezzi E., Modugno N., Fabbrini G., Berardelli A. Lack of LTP-like plasticity in primary motor cortex in Parkinson's disease. Experimental Neurology 2011, 227:296-301.
155. Tork I. Anatomy of the serotonergic system. Annals of the New York Academy of Sciences 1990, 600:9-34.
156. Ueki Y., Mima T., Ali Kotb M., Sawada H., Saiki H., Ikeda A., Begum T., Reza F., Nagamine T., Fukuyama H. Altered plasticity of the human motor cortex in Parkinson's disease. Annals of Neurology 2006, 59:60-71.
157. Valalik I., Emri M., Lengyel Z., Mikecz P., Tron L., Csokay A., Marian T. Pallidal deep brain stimulation and l-DOPA effect on PET motor activation in advanced parkinson's disease. Journal of Neuroimaging 2009, 19:253-258.
158. Viaro R., Morari M., Franchi G. Progressive motor cortex functional reorganization following 6-hydroxydopamine lesioning in rats. Journal of Neuroscience 2011, 31:4544-4554.
159. Wagle-Shukla A., Angel M.J., Zadikoff C., Enjati M., Gunraj C., Lang A.E., Chen R. Low-frequency repetitive transcranial magnetic stimulation for treatment of levodopa-induced dyskinesias. Neurology 2007, 68:704-705.
160. Watts R.L., Mandir A.S. The role of motor cortex in the pathophysiology of voluntary movement deficits associated with parkinsonism. Neurology Clinics 1992, 10:451-469.
161. Weiler N., Wood L., Yu J., Solla S.A., Shepherd G.M. Top-down laminar organization of the excitatory network in motor cortex. Nature Neuroscience 2008, 11:360-366.
162. Wichmann T., DeLong M.R. Functional and pathophysiological models of the basal ganglia. Current Opinion in Neurobiology 1996, 6:751-758.
163. Williams D., Tijssen M., Van Bruggen G., Bosch A., Insola A., Di Lazzaro V., Mazzone P., Oliviero A., Quartarone A., Speelman H., Brown P. Dopamine-dependent changes in the functional connectivity between basal ganglia and cerebral cortex in humans. Brain 2002, 125:1558-1569.
164. Williams S.M., Goldman-Rakic P.S. Widespread origin of the primate mesofrontal dopamine system. Cerebral Cortex 1998, 8:321-345.
165. Wilson C.J. Morphology and synaptic connections of crossed corticostriatal neurons in the rat. Journal of Comparative Neurology 1987, 263:567-580.
166. Wolf E., Seppi K., Katzenschlager R., Hochschorner G., Ransmayr G., Schwingenschuh P., Ott E., Kloiber I., Haubenberger D., Auff E., Poewe W. Long-term antidyskinetic efficacy of amantadine in Parkinson's disease. Movement Disorders 2010, 25:1357-1363.
167. Wu A.D., Fregni F., Simon D.K., Deblieck C., Pascual-Leone A. Noninvasive brain stimulation for Parkinson's disease and dystonia. Neurotherapeutics 2008, 5:345-361.
168. Yamawaki N., Stanford I.M., Hall S.D., Woodhall G.L. Pharmacologically induced and stimulus evoked rhythmic neuronal oscillatory activity in the primary motor cortex in vitro. Neuroscience 2008, 151:386-395.
169. Yu H., Sternad D., Corcos D.M., Vaillancourt D.E. Role of hyperactive cerebellum and motor cortex in Parkinson's disease. Neuroimage 2007, 35:222-233.
170. Zarow C., Lyness S.A., Mortimer J.A., Chui H.C. Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. Archives of Neurology 2003, 60:337-341.
171. Ziemann U., Bruns D., Paulus W. Enhancement of human motor cortex inhibition by the dopamine receptor agonist pergolide: evidence from transcranial magnetic stimulation. Neuroscience Letters 1996, 208:187-190.